Dr Marc Rigau Cortal
Honorary Fellow
Department of Microbiology and Immunology
10 Scholarly works
1 Projects
HIGHLIGHTS
2024
Journal article
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers
DOI: 10.1038/s41590-024-01892-z2023
Conference Proceedings
442-P Characterizing human Vδ1 and Vδ2 γδ T cells for tumor immunotherapy development
DOI: 10.1136/jitc-2023-sitc2023.0442-p2023
Journal article
Cytokines enhance human Vγ9Vδ2 T-cell TCR-dependent and TCR-independent effector functions
DOI: 10.1002/eji.2022502202022
Conference Proceedings
CHARACTERIZATION OF ANTIBODIES AGAINST BTN2A1 FOR Vδ2 gd T CELL-BASED TUMOR IMMUNOTHERAPY
DOI: 10.1136/jitc-2022-SITC2022.01922022
Research Grant
Optimisation of the Phosphoantigen-Reactive Gamma-Delta T-Cell Receptor for Use in Adoptive T-Cell Therapy Against the Most Common Blood and Solid Tumours in the Australian Population
2021
Journal article
Targeting butyrophilins for cancer immunotherapy
DOI: 10.1016/j.it.2021.06.0022020
Journal article
Immune recognition of phosphoantigen-butyrophilin molecular complexes by γδ T cells
DOI: 10.1111/imr.12923
RECENT SCHOLARLY WORKS
2020
Journal article
Butyrophilin molecules govern γδ T cell reactivity against phosphoantigens
DOI: 10.4049/jimmunol.204.supp.140.122020
Conference Proceedings
Butyrophilin molecules govern γδ T cell reactivity against phosphoantigens
2020
Journal article
Butyrophilin 2A1 is essential for phosphoantigen reactivity by gamma delta T cells
DOI: 10.1126/science.aay55162020
Thesis / Dissertation
Recognition of Butyrophilin-family Members by gamma-delta T Cells